{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:38:37Z","timestamp":1763415517487,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>To identify mechanisms of cortical plasticity of the visual cortex and to quantify their significance, sensitive parameters are warranted. In this context, multifocal visual evoked potentials (mfVEPs) can make a valuable contribution as they are not associated with cancellation artifacts and include also the peripheral visual field.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>To investigate if occipital repetitive transcranial magnetic stimulation (rTMS) can induce mfVEP changes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>18 healthy participants were included in a single-blind crossover-study receiving sessions of excitatory, occipital 10\u00a0Hz rTMS and sham stimulation. MfVEP was performed before and after each rTMS session and changes in amplitude and latency between both sessions were compared using generalized estimation equation models.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>There was no significant difference in amplitude or latency between verum and sham group.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We conclude that occipital 10\u00a0Hz rTMS has no effect on mfVEP measures, which is in line with previous studies using full field VEP.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12868-020-00600-5","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:03:53Z","timestamp":1606161833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Occipital repetitive transcranial magnetic stimulation does not affect multifocal visual evoked potentials"],"prefix":"10.1186","volume":"21","author":[{"given":"Robert","family":"Kolbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aykut","family":"Aytulun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kristin","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Ringelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan Jun","family":"Groiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7987-658X","authenticated-orcid":false,"given":"Philipp","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"600_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00004691-199101000-00005","volume":"8","author":"AT Barker","year":"1991","unstructured":"Barker AT. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiol. 1991;8:26\u201337. https:\/\/doi.org\/10.1097\/00004691-199101000-00005.","journal-title":"J Clin Neurophysiol"},{"issue":"4","key":"600_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/117.4.847","volume":"117","author":"A Pascual-Leone","year":"1994","unstructured":"Pascual-Leone A, Valls-Sol\u00e9 J, Wassermann EM, Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994;117(4):847\u201358.","journal-title":"Brain"},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.54.7.1529","volume":"54","author":"B Boroojerdi","year":"2000","unstructured":"Boroojerdi B, Prager A, Muellbacher W, Cohen LG. Reduction of human visual cortex excitability using 1-Hz transcranial magnetic stimulation. Neurology. 2000;54:1529\u201331.","journal-title":"Neurology"},{"key":"600_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00006324-199405000-00001","volume":"71","author":"E Marg","year":"1994","unstructured":"Marg E, Rudiak D. Phosphenes induced by magnetic stimulation over the occipital brain: description and probable site of stimulation. Optom Vis Sci. 1994;71:301\u201311.","journal-title":"Optom Vis Sci"},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00221-004-1992-0","volume":"160","author":"T Kammer","year":"2005","unstructured":"Kammer T, Puls K, Erb M, Grodd W. Transcranial magnetic stimulation in the visual system. II. Characterization of induced phosphenes and scotomas. Exp Brain Res. 2005;160:129\u201340. https:\/\/doi.org\/10.1007\/s00221-004-1992-0.","journal-title":"Exp Brain Res"},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brs.2016.11.009","volume":"10","author":"G Cirillo","year":"2017","unstructured":"Cirillo G, Di Pino G, Capone F, Ranieri F, Florio L, Todisco V, et al. Neurobiological after-effects of non-invasive brain stimulation. Brain Stimul. 2017;10:1\u201318. https:\/\/doi.org\/10.1016\/j.brs.2016.11.009.","journal-title":"Brain Stimul"},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/brain\/awf081","volume":"125","author":"V Bohotin","year":"2002","unstructured":"Bohotin V, Fumal A, Vandenheede M, G\u00e9rard P, Bohotin C, Maertens De Noordhout A, et al. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain. 2002;125:912\u201322. https:\/\/doi.org\/10.1093\/brain\/awf081.","journal-title":"Brain"},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/j.clinph.2014.01.028","volume":"125","author":"PM Omland","year":"2014","unstructured":"Omland PM, Uglem M, Engstr\u00f8m M, Linde M, Hagen K, Sand T. Modulation of visual evoked potentials by high-frequency repetitive transcranial magnetic stimulation in migraineurs. Clin Neurophysiol. 2014;125:2090\u20139. https:\/\/doi.org\/10.1016\/j.clinph.2014.01.028.","journal-title":"Clin Neurophysiol"},{"key":"600_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0013-4694(94)90114-7","volume":"90","author":"HA Baseler","year":"1994","unstructured":"Baseler HA, Sutter EE, Klein SA, Carney T. The topography of visual evoked response properties across the visual field. Electroencephalogr Clin Neurophysiol. 1994;90:65\u201381. https:\/\/doi.org\/10.1016\/0013-4694(94)90114-7.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/6.5.4","volume":"6","author":"DC Hood","year":"2006","unstructured":"Hood DC, Ghadiali Q, Zhang JC, Graham NV, Wolfson SS, Zhang X. Contrast\u2013response functions for multifocal visual evoked potentials: A test of a model relating V1 activity to multifocal visual evoked potentials activity. J Vis. 2006;6:4. https:\/\/doi.org\/10.1167\/6.5.4.","journal-title":"J Vis"},{"key":"600_CR11","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.clinph.2014.12.014","volume":"126","author":"CJ Hartmann","year":"2015","unstructured":"Hartmann CJ, Klistorner AI, Brandt AU, Schroeder K, Kolbe R, Cohn E, et al. Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials. Clin Neurophysiol. 2015;126:2040\u20131. https:\/\/doi.org\/10.1016\/j.clinph.2014.12.014.","journal-title":"Clin Neurophysiol"},{"key":"600_CR12","first-page":"2145","volume":"42","author":"AI Klistorner","year":"2001","unstructured":"Klistorner AI, Graham SL. Electroencephalogram-based scaling of multifocal visual evoked potentials: Effect on intersubject amplitude variability. Investig Ophthalmol Vis Sci. 2001;42:2145\u201352.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"600_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.clinph.2015.02.001","volume":"126","author":"PM Rossini","year":"2015","unstructured":"Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee. Clin Neurophysiol. 2015;126:1071\u2013107. https:\/\/doi.org\/10.1016\/j.clinph.2015.02.001.","journal-title":"Clin Neurophysiol"},{"key":"600_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10633-014-9467-5","volume":"130","author":"D Narayanan","year":"2015","unstructured":"Narayanan D, Cheng H, Tang RA, Frishman LJ. Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes. Doc Ophthalmol. 2015;130:31\u201341. https:\/\/doi.org\/10.1007\/s10633-014-9467-5.","journal-title":"Doc Ophthalmol"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-020-00600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12868-020-00600-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-020-00600-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:11:54Z","timestamp":1606162314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-020-00600-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1186\/s12868-020-00600-5","relation":{},"ISSN":["1471-2202"],"issn-type":[{"type":"electronic","value":"1471-2202"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee (study number 4850) of the medical faculty of the Heinrich-Heine University of D\u00fcsseldorf (Ethikkommission der Medizinischen Fakult\u00e4t der Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf) and has been performed complying with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We report the following conflicts of interest which are all unrelated to the work presented.Robert Kolbe, Aykut Aytulun, Ann-Kristin M\u00fcller declares no conflicts of interest. Marius Ringelstein received speaker honoraria from Novartis, Bayer Vital GmbH, and Ipsen and travel reimbursement from Bayer Schering, Biogen idec, Merz, Genzyme, Teva and Merck. Orhan Aktas received grants from the German Research Foundation (DFG) and the German Ministry of Education and Research (BMBF); grants and personal fees from Bayer HealthCare, Biogen, Genzyme, Novartis, and Teva; and personal fees from Almirall, MedImmune, Merck Serono, and Roche. Alfons Schnitzler received honoraria for speaking\/consulting for Medtronic, Boston Scientific, Abbott\/SJM, Gr\u00fcnenthal, Abbvie, UCB, MEDA Pharma, GlaxoSmithKline, and Teva. Hans-Peter Hartung has received fees outside this work for serving on steering committees from Biogen Idec, GeNeuro, Sanofi Genzyme, Merck, Novartis Pharmaceuticals, Octapharma, Opexa Therapeutics, Teva Pharmaceuticals, MedImmune, Bayer HealthCare, Forward Pharma, and Roche; fees for serving on advisory boards from Biogen Idec, Sanofi Genzyme, Merck, Novartis Pharmaceuticals, Octapharma, Opexa Therapeutics, Teva Pharmaceuticals, and Roche; and lecture fees from Biogen Idec, Sanofi Genzyme, Merck, Novartis Pharmaceuticals, Octapharma, Opexa Therapeutics, Teva Pharmaceuticals, MedImmune, and Roche. The MS Center at the Department of Neurology in D\u00fcsseldorf is supported in part by the Walter and Ilse Rose Foundation. Stefan Jun Groiss received honoraria and\/or travel expenses in the past from Medtronic, Abbott Laboratories, Boston Scientific, Rogue Research and UCB. Philipp Albrecht received compensation for serving on Scientific Advisory Boards for Ipsen, Novartis, and Biogen; he received speaker honoraria and travel support from Novartis, Teva, Biogen, Merz Pharmaceuticals, Ipsen, Allergan, Bayer HealthCare, Esai, UCB and Glaxo Smith Kline; he received research support from Novartis, Biogen, Teva, Merz Pharmaceuticals, Ipsen, and Roche. The MS Center at the Department of Neurology in D\u00fcsseldorf is supported in part by the Walter and Ilse Rose Foundation by grants to H.-P.H.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}